Pasithea Therapeutics Cor... (KTTAW)
0.03
0.00 (19.52%)
At close: Jan 07, 2025, 9:00 PM
undefined% (undefined)
| Bid | 0.03 |
| Market Cap | 2.57M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.03 |
| Volume | 5,669 |
| Avg. Volume (20D) | 0 |
| Open | 0.03 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Beta | undefined |
About KTTAW
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida....
Industry Biotechnology
Sector Healthcare
IPO Date Sep 15, 2021
Employees 8
Stock Exchange NASDAQ
Ticker Symbol KTTAW
Website http://pasitheaclinics.com